Low-density lipoproteins receptor (LDLR) liver gene therapy normalizes LDL cholesterol (LDL-C) and prevents atherosclerosis in a familial hypercholesterolemia (FH) mouse model
Saved in:
Published in | Atherosclerosis Vol. 395; p. 118281 |
---|---|
Main Authors | , , , , , , , , , |
Format | Journal Article |
Language | English |
Published |
Elsevier B.V
01.08.2024
|
Online Access | Get full text |
ISSN | 0021-9150 |
DOI | 10.1016/j.atherosclerosis.2024.118281 |
Cover
ISSN: | 0021-9150 |
---|---|
DOI: | 10.1016/j.atherosclerosis.2024.118281 |